Pathological complete response after afatinib treatment of stage IV oligometastatic adenocarcinoma of the lung: the role of pulmonary surgery.

Ping-Chung TsaiYi-Chen YehChien-Sheng HuangChao-Hua Chiu

Published in: Surgical case reports (2019)

Our case provides additional data to support that tissue assessment through primary lung tumor resection after systemic treatment of oligometastic lung cancer by minimally invasive surgery can reveal the treatment effect and potentially provide a surrogate endpoint in further clinical trials.

Keyphrases

clinical trial
squamous cell carcinoma
minimally invasive
randomized controlled trial
gene expression
machine learning
percutaneous coronary intervention
replacement therapy
locally advanced
phase ii